Tags : PREPARE study

Novavax Reports Results of ResVax in P-III PREPARE Trial for

Shots: The P-III PREPARE study involves assessing ResVax vs PBO in 4,636 pregnant women to prevent the risk of RSV Disease in infants PREPARE study results: didn’t met 1EPs @prevention of medically significant RSV LRTI; 39% against medically significant RSV LRTI; 44% against RSV LRTI hospitalizations; 48% against RSV LRTI with severe hypoxemia; reduction in […]Read More